HOME >> BIOLOGY >> NEWS
UI Laboratory Develops Procedure To Study DNA Replication

IOWA CITY, Iowa -- A University of Iowa research team has developed a way to isolate replicating deoxyribonucleic acid (DNA) molecules that scientists then can use to examine the replication process under controlled conditions. This advance will allow investigators to better understand DNA replication and may lead to improved therapies for treating diseases such as cancer.

"One of the difficulties with studying the DNA replication process is that there are multiple protein complexes involved, and it is difficult to experimentally dissect individual reactions that are occurring," said Marc Wold, Ph.D., UI associate professor of biochemistry and the project's principal investigator. "Our procedure will allow us to examine these reactions in more detail."

DNA is the genetic material that encodes all components in human cells. Each cell contains more than two meters of DNA. Every time a cell divides, it is necessary to duplicate all of its DNA.

Using DNA derived from the Simian Virus 40 from monkeys, Wold and members of his laboratory let DNA replication start in an extract from human cells. The researchers attach magnetic beads to the DNA molecules and use a magnet to isolate the molecules and associated replication proteins. The researchers can then manipulate the extracted DNA and add specific replication proteins in a controlled manner to understand the mechanics of DNA replication.

"This will mean we can start asking specific questions about the reactions during replication and learn more about the specific roles of replication proteins," Wold said.

The advantage of this system is that it allows separation of the DNA replication process from the synthetic reactions. This separation has been difficult to achieve in previous replication systems.

Using his technique, Wold hopes that his lab and others can begin to understand what causes some cells to mutate. DNA replication is a complex process that is very accurate and highly regulate
'"/>

Contact: Jennifer Cronin
jennifer-cronin@uiowa.edu
319-335-9917
University of Iowa
30-Mar-1999


Page: 1 2

Related biology news :

1. Laboratory grows world record length carbon nanotube
2. Story tips from the Department of Energys Oak Ridge National Laboratory, September 2004
3. Pacific Northwest National Laboratory gets $10 million from NIH to build virtual lung
4. Story tips from the Department of Energys Oak Ridge National Laboratory, August 2004
5. Story tips from the Department of Energys Oak Ridge National Laboratory, July 2004
6. Oak Ridge National Laboratory to develop DOE leadership-class computing capability for science
7. Institute for Systems Biology, Pacific Northwest National Laboratory announce collaboration
8. Story tips from the Department of Energys Oak Ridge National Laboratory, April 2004
9. Laboratory rat gene sequencing completed
10. ORNL earns four Federal Laboratory Consortium awards
11. Story tips from the Department of Energys Oak Ridge National Laboratory, February 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Laboratory Develops Procedure Study DNA Replication

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: